As for CXCL10, it can be advocated that an initial more robust TH1 response with monocytes/macrophage over activation in COVID-19 patients, as compared to non-COVID-19 patients, could lead to a subsequent IL-10 overproduction in order to limit T cell responses. This evidence concerns the gene CXCL10 and COVID-19.